Free tool
Drug Trial Radar
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 19, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
64,782
Completed, industry sponsors
By trial status
The same filters, counted in each status. Pick one to switch.
- Recruiting7,024
- Not yet recruiting2,256
- Completed64,782
64,782 trials
Showing 1 to 25, recently updated first.
Ocular Therapeutix, Inc.Industry
NCT05695417 · 22 participants · Start Jan 15, 2023 · Primary completion May 28, 2024
Drug: OTX-TKI; Sham · For: Non-proliferative Diabetic Retinopathy
Sites: Phoenix, Arizona; Bakersfield, California; Augusta, Georgia · 10 sites in all
Arcutis Biotherapeutics, Inc.Industry
NCT06998056 · 101 participants · Start Jun 9, 2025 · Primary completion Dec 4, 2025
Drug: ARQ-151 cream 0.05% · For: Atopic Dermatitis (Eczema)
Sites: Birmingham, Alabama; Bryant, Arkansas; Fountain Valley, California · 22 sites in all
- Study of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaCompleted
Suzhou Junde Biotechnology Co., LtdIndustry
NCT04843098 · 13 participants · Start May 26, 2021 · Primary completion Nov 20, 2024
Drug: TL117; Paclitaxel · For: Head and Neck Squamous Cell Carcinoma
Sites: Shanghai, China
- Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisPivotal-lookingCompleted
Bausch Health Americas, Inc.Industry
NCT05071716 · 524 participants · Start Apr 7, 2022 · Primary completion Dec 23, 2025
Drug: Rifaximin SSD; Placebo · For: Hepatic Encephalopathy
Sites: Dothan, Alabama; Chandler, Arizona; Peoria, Arizona · 150 sites in all
- Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous DosePivotal-lookingCompleted
AmgenAmgen (AMGN)
NCT07422285 · 405 participants · Start Jan 16, 2026 · Primary completion Jul 24, 2026
Drug: Evolocumab Drug Substance A; Evolocumab Drug Substance B · For: Healthy Participants; Pharmacokinetics
Sites: Springfield, Missouri; Columbus, Ohio; Dallas, Texas · 4 sites in all
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.Industry
NCT03125746 · 24 participants · Start Jun 12, 2017 · Primary completion Jul 21, 2021
Drug: LXI-15029; LXI-15029+Exemestane · For: Advanced Breast Cancer
Sites: Beijing, China
- Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver DiseasePivotal-lookingCompleted
Novo Nordisk A/SNovo Nordisk (NVO)
NCT06409130 · 270 participants · Start May 20, 2024 · Primary completion Nov 21, 2025
Drug: NNC0194-0499; Semaglutide and 6 more · For: Alcohol-related Liver Disease
Sites: Chandler, Arizona; Tucson, Arizona; Lancaster, California · 102 sites in all
Heron TherapeuticsIndustry
NCT05434663 · 24 participants · Start May 13, 2022 · Primary completion Sep 18, 2023
Drug: SUSTOL · For: Chemotherapy-Induced Nausea and Vomiting (CINV)
Sites: Hattiesburg, Mississippi; Canton, Ohio
- Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's DiseasePivotal-lookingCompleted
AriBio Co., Ltd.Industry
NCT03625622 · 210 participants · Start Apr 1, 2019 · Primary completion Dec 21, 2020
Drug: AR1001 10mg; Placebo and 1 more · For: Mild to Moderate Alzheimer's Disease
Sites: Banning, California; Sacramento, California; Santa Ana, California · 21 sites in all
- Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate CancerPivotal-lookingCompleted
Curium US LLCIndustry
NCT06235151 · 443 participants · Start Apr 1, 2024 · Primary completion Oct 30, 2026
Drug: Copper Cu 64 PSMA I&T · For: Prostate Cancer; Prostate Adenocarcinoma
Sites: Homewood, Alabama; Little Rock, Arkansas; Fullerton, California · 43 sites in all
- Halova Vaginal Ovules Versus Vaginal Estriol for Genitourinary Symptoms in Postmenopausal WomenCompleted
Perfect Care DistributionIndustry
NCT07932990 · 252 participants · Start Mar 7, 2025 · Primary completion Apr 22, 2026
Drug: Estriol 0.5 mg vaginal ovules · For: Genitourinary Syndrome of Menopause (GSM); Vaginal Dryness; Vulvo Vaginal Atrophy (VVA)
Sites: Arad, Romania
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.Industry
NCT06561542 · 100 participants · Start Aug 5, 2024 · Primary completion Jan 23, 2025
Drug: LX22001 for Injeciton; Tegoprazan tablet and 1 more · For: Healthy
Sites: Beijing, China
AbbVieAbbVie (ABBV)
NCT03386513 · 179 participants · Start Jan 2, 2018 · Primary completion Oct 2, 2024
Drug: IMGN632 · For: Blastic Plasmacytoid Dendritic Cell Neoplasm; Myeloproliferative Neoplasm
Sites: Birmingham, Alabama; Gilbert, Arizona; Duarte, California · 18 sites in all
GPCR Therapeutics, Inc.Industry
NCT05561751 · 28 participants · Start Feb 13, 2023 · Primary completion Sep 30, 2025
Drug: GPC-100; Propranolol and 1 more · For: Multiple Myeloma
Sites: La Jolla, California; Gainesville, Florida; Indianapolis, Indiana · 10 sites in all
Provention Bio, a Sanofi CompanyIndustry
NCT04598893 · 188 participants · Start Oct 26, 2020 · Primary completion Nov 12, 2026
Drug: Teplizumab · For: Diabetes Mellitus, Type 1
Sites: San Diego, California; San Francisco, California; Walnut Creek, California · 47 sites in all
- Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLCPivotal-lookingCompleted
Shanghai Yizhong Pharmaceutical Co., Ltd.Industry
NCT02667743 · 454 participants · Start May 2015 · Primary completion Jan 2019
Drug: Paclitaxel Micelles for Injection; Paclitaxel Injection and 1 more · For: Non-Small Cell Lung Cancer(NSCLC)
Sites: Guangzhou, China; Shanghai, China; Nanjing, China
Regeneron PharmaceuticalsRegeneron (REGN)
NCT05481333 · 64 participants · Start Oct 24, 2022 · Primary completion Aug 29, 2023
Drug: REGN7999; Placebo · For: Healthy
Sites: Ghent, Belgium
Boehringer IngelheimBoehringer Ingelheim
NCT07774325 · 10 participants · Start Sep 1, 2026 · Primary completion Oct 11, 2026
Drug: BI 3000202; Ciclosporin and 1 more · For: Healthy
Sites: Biberach, Germany
Eli Lilly and CompanyEli Lilly (LLY)
NCT07794592 · 24 participants · Start Aug 28, 2026 · Primary completion Oct 8, 2026
Drug: Olomorasib test; Olomorasib reference · For: Healthy Volunteers
Sites: Daytona Beach, Florida
Memorises BioIndustry
NCT05351437 · 32 participants · Start Apr 26, 2022 · Primary completion Sep 4, 2022
Drug: MTx-COVAB36; Placebo · For: SARS-CoV-2 Infection
Sites: Nedlands, Australia
PfizerPfizer (PFE)
NCT06898047 · 250 participants · Start Nov 15, 2025 · Primary completion Oct 24, 2026
Drug: Rimegepant for acute migraine treatment · For: Migraine
Sites: London, United Kingdom
Strand Therapeutics Inc.Industry
NCT06249048 · 39 participants · Start May 3, 2024 · Primary completion Jun 17, 2026
Drug: STX-001; Keytruda® · For: Advanced Solid Tumor
Sites: Scottsdale, Arizona; Beverly Hills, California; Cleveland, Ohio · 7 sites in all
Regeneron PharmaceuticalsRegeneron (REGN)
NCT03005782 · 333 participants · Start Nov 7, 2016 · Primary completion Apr 2, 2024
Drug: REGN3767; cemiplimab · For: Malignancies
Sites: Encinitas, California; Fresno, California; La Jolla, California · 43 sites in all
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorPivotal-lookingCompleted
Novo Nordisk A/SNovo Nordisk (NVO)
NCT06065540 · 2,734 participants · Start Sep 27, 2023 · Primary completion Nov 19, 2025
Drug: Cagrilintide; Semaglutide and 2 more · For: Type 2 Diabetes Mellitus
Sites: Birmingham, Alabama; Pelham, Alabama; Phoenix, Arizona · 405 sites in all
- Phase II Clinical Trial of PCV24 in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 MonthsPivotal-lookingCompleted
Reinovax Biologics Co., LTDIndustry
NCT07333352 · 480 participants · Start Sep 11, 2025 · Primary completion Apr 14, 2026
Drug: 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine (RZ700); 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (Prevnar 13) · For: Pneumococcal Infectious Disease
Sites: Changzhi, China; Yangquan, China; Yuncheng, China · 7 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.